Clinical Trial Update: Superdonor FMT in Patients With Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a Superdonor fecal microbiota transplant in patients with active ulcerative colitis, currently recruiting in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Superdonor Fecal Microbiota Transplant (fecal microbiota transplant)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Active Ulcerative Colitis | Phase 1, Phase 2 | Status: RECRUITING